Finance

Lists
Why is 3164 down 2.35%?
Dive Deeper
3164:TPE
GenMont Biotech Inc
NT$16.60
-2.35%
(-0.40) 1D
Nov 13, 1:30:00 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 3164...
Open
NT$17.00
High
NT$17.00
Low
NT$16.50
Mkt. cap
1.43B
Avg. vol.
50.44K
Volume
38.21K
Dividend
4.82%
Quarterly dividend
NT$0.20
Ex-dividend date
Apr 8, 2026
P/E ratio
23.11
52-wk high
NT$19.75
52-wk low
NT$15.35
EPS
NT$0.72
Shares outstanding
88.91M
No. of employees
147
Open
NT$17.00
High
NT$17.00
Low
NT$16.50
Mkt. cap
1.43B
Avg. vol.
50.44K
Volume
38.21K
Dividend
4.82%
Quarterly dividend
NT$0.20
Ex-dividend date
Apr 8, 2026
P/E ratio
23.11
52-wk high
NT$19.75
52-wk low
NT$15.35
EPS
NT$0.72
Shares outstanding
88.91M
No. of employees
147
News stories
From web sources and news partners
About GenMont Biotech Inc
CEO-
Employees147
Founded2000
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegenmont.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
100.70M
89.17M
103.33M
103.43M
Cost of goods sold
38.03M
40.95M
42.22M
41.12M
Cost of revenue
38.03M
40.95M
42.22M
41.12M
Research and development expenses
11.62M
10.48M
11.40M
10.88M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
38.04M
35.28M
36.36M
-
Operating expense
50.91M
55.40M
46.42M
43.07M
Total operating expenses
88.94M
96.35M
88.64M
84.19M
Operating income
11.76M
-7.18M
14.70M
19.24M
Other non operating income
374.00K
61.00K
81.00K
2.96M
EBT including unusual items
29.47M
3.38M
19.56M
23.97M
EBT excluding unusual items
29.47M
3.38M
19.56M
23.97M
Income tax expense
7.16M
1.58M
6.70M
-
Effective tax rate
24.31%
46.60%
34.27%
38.20%
Other operating expenses
-
-
-
-
Net income
24.80M
4.15M
15.54M
-
Net profit margin
24.62%
4.65%
15.04%
16.94%
Earnings per share
-
-
-
-
Interest and investment income
1.55M
1.62M
1.69M
1.77M
Interest expense
-900.00K
-937.00K
-1.03M
-
Net interest expenses
651.00K
685.00K
654.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
27.26M
9.11M
31.09M
38.84M
Gain or loss from assets sale
1.00K
-
7.00K
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps